Question: Is high-dose (>12 mg) buprenorphine induction safe and well tolerated in patients with untreated opioid use disorder who present to the emergency department? Findings: In this case series of 579 cases, 54 clinicians followed a high-dose buprenorphine (monoproduct) protocol. There were no documented episodes of respiratory depression or excessive sedation, and precipitated withdrawal was rare (0.8% of cases) and was not associated with dosing. Meaning: These findings suggest that high-dose buprenorphine induction, adopted by multiple clinicians in a single-site, urban emergency department, was safe and well tolerated in patients with untreated opioid use disorder
ObjectiveTo identify individual and site-related factors associated with frequent emergency departme...
Question: What is the consensus of experts in palliative care, addiction, or both on the appropriat...
Question: How does the risk of overdose change with the number of days with concurrent opioid and b...
Question: What is the real-world effectiveness of different treatment pathways for opioid use disor...
Question: Is the risk of opioid-related emergency department visit, hospital admission, or death as...
Buprenorphine, a partial opioid agonist, has pharmacological features, including safety at overdose ...
Compared with unsupervised consumption of a long‐acting opioid substitution medication or routine co...
Introduction: Recent studies from urban academic centers have shown the promise of emergency physici...
Compared with buprenorphine, low‐certainty evidence suggests that dihydrocodeine for detoxification ...
Buprenorphine seems to provide benefits over adrenergic agonists in terms of reduction of withdrawal...
Background: Opioid-involved deaths in the United States have risen steadily since 2018, from 47,000 ...
INTRODUCTION: Buprenorphine is highly effective for the treatment of opioid use disorder (OUD), and,...
Introduction: Prescribing of buprenorphine and naloxone in the emergency department (ED) has been sh...
Introduction: Opioid abuse and overdose deaths have reached epidemic proportions in the last couple ...
International audienceBACKGROUND: National health monitoring agencies have reported the alternative ...
ObjectiveTo identify individual and site-related factors associated with frequent emergency departme...
Question: What is the consensus of experts in palliative care, addiction, or both on the appropriat...
Question: How does the risk of overdose change with the number of days with concurrent opioid and b...
Question: What is the real-world effectiveness of different treatment pathways for opioid use disor...
Question: Is the risk of opioid-related emergency department visit, hospital admission, or death as...
Buprenorphine, a partial opioid agonist, has pharmacological features, including safety at overdose ...
Compared with unsupervised consumption of a long‐acting opioid substitution medication or routine co...
Introduction: Recent studies from urban academic centers have shown the promise of emergency physici...
Compared with buprenorphine, low‐certainty evidence suggests that dihydrocodeine for detoxification ...
Buprenorphine seems to provide benefits over adrenergic agonists in terms of reduction of withdrawal...
Background: Opioid-involved deaths in the United States have risen steadily since 2018, from 47,000 ...
INTRODUCTION: Buprenorphine is highly effective for the treatment of opioid use disorder (OUD), and,...
Introduction: Prescribing of buprenorphine and naloxone in the emergency department (ED) has been sh...
Introduction: Opioid abuse and overdose deaths have reached epidemic proportions in the last couple ...
International audienceBACKGROUND: National health monitoring agencies have reported the alternative ...
ObjectiveTo identify individual and site-related factors associated with frequent emergency departme...
Question: What is the consensus of experts in palliative care, addiction, or both on the appropriat...
Question: How does the risk of overdose change with the number of days with concurrent opioid and b...